Complementary & Alternative Medicine
Effects of dosing condition on bioavailability of green tea catechins examined
Published in Vaccine Weekly, August 10th, 2005
"Green tea has been shown to exhibit cancer-preventive activities in preclinical studies. Its consumption has been associated with decreased risk of certain types of cancers in humans," investigators in the United States reported.
"The oral bioavailability of the major green tea constituents, green tea catechins, is low, resulting in systemic catechin levels in humans many fold less than the effective concentrations determined in in vitro systems. We conducted this clinical study to test the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-08-10)
More Articles from Vaccine Weekly
- Breast Cancer Vaccine
A Tat fusion protein-based tumor vaccine for breast cancer developed - Chickenpox Vaccine
Oka/GSK attenuated varicella vaccine prevents chickenpox in clinical practice - HIV/AIDS Vaccine
Cross-reactivity of anti-HIV immune responses of major HIV-1 clades reported - Monoclonal Antibodies
Plant biopharming of monoclonal antibodies reviewed - Vector Development
Intracarotid delivery of oncolytic HSV vector to brain cancer reported - Animal Models
Nonhuman primates are models for hematology, immunology, and virology studies - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
